Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 14/20 | 0.54 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.52 |
| ▸ | GLP1R | P43220 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30093071 | 0.96 | C5AR1 (0.54) | KISS1RC5AR1GLP1R | |
| SCHEMBL30130533 | 0.96 | C5AR1 (0.55) | KISS1RC5AR1GLP1R | |
| SCHEMBL30092961 | 0.95 | C5AR1 (0.50) | KISS1RC5AR1GLP1R | |
| SCHEMBL30093002 | 0.92 | C5AR1 (0.55) | KISS1RC5AR1GLP1R | |
| SCHEMBL30093066 | 0.91 | C5AR1 (0.53) | KISS1RC5AR1GLP1R | |
| SCHEMBL30093064 | 0.91 | C5AR1 (0.53) | KISS1RC5AR1GLP1R | |
| SCHEMBL30130567 | 0.91 | C5AR1 (0.61) | C5AR1GLP1R | |
| SCHEMBL30130535 | 0.91 | C5AR1 (0.61) | C5AR1GLP1R | |
| SCHEMBL30093087 | 0.90 | C5AR1 (0.60) | C5AR1GLP1R | |
| SCHEMBL31510146 | 0.89 | CTSL (0.51) | KISS1RC5AR1GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287044-A1 | NOVEL ANTIBACTERIAL PEPTIDE AND USE THEREOF | ANYGEN CO., LTD. (KR) | 2023-09-14 | — | — | US | claimed |
| US-20230287044-A1 | NOVEL ANTIBACTERIAL PEPTIDE AND USE THEREOF | ANYGEN CO., LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| EP-4129064-A1 | NOVEL ANTIBACTERIAL PEPTIDE AND USE THEREOF | Anygen Co., Ltd. (KR) | 2023-02-08 | — | — | EP | disclosed |
| CN-115397836-A | Novel antibacterial peptide and application thereof | 安尼根有限公司 | 2022-11-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287044-A1 | NOVEL ANTIBACTERIAL PEPTIDE AND USE THEREOF | VIP, CUTA, LNPEP | KISS1R 1140/4885C5AR1 1231/4885GLP1R 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.